A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

NCT01400646 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rivaroxaban
DRUG: Warfarin
DRUG: Vitamin K
DRUG: Vitamin K
DRUG: Warfarin
DRUG: Warfarin
DRUG: Warfarin

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]